tiprankstipranks
Advertisement
Advertisement
Ionis Pharmaceuticals price target raised to $115 from $106 at Barclays
PremiumThe FlyIonis Pharmaceuticals price target raised to $115 from $106 at Barclays
25d ago
Ionis Pharmaceuticals’ Earnings Call Flags Growth and Risks
Premium
Company Announcements
Ionis Pharmaceuticals’ Earnings Call Flags Growth and Risks
26d ago
Analyst Reiterates Buy Rating on Ionis Pharmaceuticals, Maintains $105 Price Target on Strong Q1 and Upgraded Olezarsen Outlook
Premium
Ratings
Analyst Reiterates Buy Rating on Ionis Pharmaceuticals, Maintains $105 Price Target on Strong Q1 and Upgraded Olezarsen Outlook
26d ago
Ionis Pharmaceuticals price target lowered to $108 from $110 at TD Cowen
PremiumThe FlyIonis Pharmaceuticals price target lowered to $108 from $110 at TD Cowen
1M ago
Ionis Pharmaceuticals: Advancing Neurology Franchise Underscored by Zilganersen’s Strong Phase III Data in Alexander Disease
Premium
Ratings
Ionis Pharmaceuticals: Advancing Neurology Franchise Underscored by Zilganersen’s Strong Phase III Data in Alexander Disease
1M ago
Ionis Expands Its Rare Epilepsy Pipeline With New ASCEND Trial in Dravet Syndrome
Premium
Company Announcements
Ionis Expands Its Rare Epilepsy Pipeline With New ASCEND Trial in Dravet Syndrome
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100